09.12.2014
- At a special meeting held at the Sigma-Aldrich Life Science and Technology Center in St. Louis, Missouri, USA, 78% of the company's shareholders approved the planned takeover by...
19.09.2014
- The decision by Swiss drugmaker Roche in August to buy US biotech company InterMune for $8.3 billion was "exceptional" and not a sign of more ambitious plans for major acquisitions...
